Human beta-defensin 3 induces maturation of human langerhans cell-like dendritic cells: An antimicrobial peptide that functions as an endogenous adjuvant

Journal of Investigative Dermatology

Volumn 133, Issue 2, 2013, Pages 460-468

  Ferris, Laura K ^a   Mburu, Yvonne K ^a   Mathers, Alicia R ^a   Fluharty, Eric R ^a   Larregina, Adriana T ^a   Ferris, Robert L ^a   Falo Jr , Louis D ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 3; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCL19; CHEMOKINE RECEPTOR CCL21; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ARTICLE; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; INNATE IMMUNITY; LANGERHANS CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TH1 CELL;

EID: 84872604948     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.319     Document Type: Article

References (40)

1. Berthier-Vergnes O, Bermond F, Flacher V et al. (2005) TNF-[alpha] enhances phenotypic and functional maturation of human epidermal Langerhans cells and induces IL-12 p40 and IP-10/CXCL-10 production. FEBS Lett 579:3660
2. Biragyn A, Ruffini PA, Leifer CA et al. (2002) Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298:1025-9
3. Chadebech P, Goidin D, Jacquet C et al. (2003) Use of human reconstructed epidermis to analyze the regulation of beta-defensin hBD-1, hBD-2, and hBD-3 expression in response to LPS. Cell Biol Toxicol 19:313-24
4. Davidson DJ, Currie AJ, Reid GSD et al. (2004) The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol 172:1146-56
5. De Smedt T, Pajak B, Muraille E et al. (1996) Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med 184:1413-24
6. Di Nardo A, Braff MH, Taylor KR et al. (2007) Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization. J Immunol 178:1829-34
7. Feng Z, Dubyak GR, Lederman MM et al. (2006) Cutting edge: human beta defensin 3-a novel antagonist of the HIV-1 coreceptor CXCR4. J Immunol 177:782-6
8. Flacher V, Bouschbacher M, Verronese E et al. (2006) Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria. J Immunol 177:7959-67
9. Funderburg N, Lederman MM, Feng Z et al. (2007) Human Beta-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proc Natl Acad Sci 104:18631-5
10. Geissmann F, Prost C, Monnet J-P et al. (1998) Transforming growth factor beta 1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med 187:961-6
11. Gerstel U, Czapp M, Bartels J et al. (2009) Rhamnolipid-induced shedding of flagellin from Pseudomonas aeruginosa provokes hBD-2 and IL-8 response in human keratinocytes. Cell Microbiol 11:842-53
12. Guironnet G, Dezutter-Dambuyant C, Bechetoille CVN et al. (2002) Antagonistic effects of IL-4 and TGF-{beta}1 on Langerhans cell-related antigen expression by human monocytes. J Leukoc Biol 71:845-53
13. Harder J, Bartels J, Christophers E et al. (2001) Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276:5707-13
14. He Y, Zhang J, Donahue C et al. (2006) Skin-derived dendritic cells induce potent CD8+ T cell immunity in recombinant lentivector-mediated genetic immunization. Immunity 24:643-56
15. Hollox EJ, Huffmeier U, Zeeuwen PLJM et al. (2008) Psoriasis is associated with increased [beta]-defensin genomic copy number. Nat Genet 40:23-5
16. Joly S, Organ CC, Johnson GK et al. (2005) Correlation between beta-defensin expression and induction profiles in gingival keratinocytes. Mol Immunol 42:1073-84
17. Kolls JK, McCray PB, Chan YR (2008) Cytokine-mediated regulation of antimicrobial proteins. Nat Rev Immunol 8:829-35
18. Larregina AT, Falo Jr LD (2005) Changing paradigms in cutaneous immunology: adapting with dendritic cells. J Investig Dermatol 124:1-12
19. Larregina AT, Morelli AE, Spencer LA et al. (2001) Dermal-resident CD14+ cells differentiate into Langerhans cells. Nat Immunol 2:1151-8
20. Li Q, Verma IM (2002) NF-[kappa]B regulation in the immune system. Nat Rev Immunol 2:725-34
21. Liu AY, Destoumieux D, Wong AV et al. (2002) Human [bgr]-Defensin-2 production in keratinocytes is regulated by Interleukin-1, bacteria, and the state of differentiation. J Invest Dermatol 118:275
22. Liu Y, Krueger JG, Bowcock AM (2007) Psoriasis: genetic associations and immune system changes. Genes Immun 8:1-12
23. Mburu YK, Abe K, Ferris LK et al. (2011) Human beta-defensin 3 promotes NF-kappaB-mediated CCR7 expression and anti-apoptotic signals in squamous cell carcinoma of the head and neck. Carcinogenesis 32:168-74
24. Mburu YK, Egloff AM, Walker WH et al. (2012) Chemokine receptor 7 (CCR7) gene expression is regulated by NF-kappaB and activator protein 1 (AP1) in metastatic squamous cell carcinoma of head and neck (SCCHN). J Biol Chem 287:3581-90
25. Menzies BE, Kenoyer A (2006) Signal transduction and nuclear responses in Staphylococcus aureus-induced expression of human beta-defensin 3 in skin keratinocytes. Infect Immun 74:6847-54
26. Navid F, Boniotto M, Walker C et al. (2012) Induction of regulatory T cells by a murine beta-defensin. J Immunol 188:735-43
27. Nomura I, Goleva E, Howell MD et al. (2003) Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171:3262-9
28. Ohl L, Mohaupt M, Czeloth N et al. (2004) CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21:279
29. Oppenheim JJ, Biragyn A, Kwak LW et al. (2003) Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann Rheum Dis 62(Suppl 2):ii17-21
30. Rieser C, Bock G, Klocker H et al. (1997) Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J Exp Med 186: 1603-8
31. Rohrl J, Yang D, Oppenheim JJ et al. (2010) Human {beta}-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. J Immunol 184:6688-94
32. Semple F, MacPherson H, Webb S et al. (2011) Human beta-defensin 3 affects the activity of pro-inflammatory pathways associated with MyD88 and TRIF. Eur J Immunol 41:3291-300
33. Semple F, Webb S, Li HN et al. (2010) Human beta-defensin 3 has immunosuppressive activity in vitro and in vivo. Eur J Immunol 40:1073-8
34. Sorensen OE, Cowland JB, Theilgaard-Monch K et al. (2003) Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 170:5583-9
35. Tervaert WC, Esseveld H (1970) A study of the incidence of haemolytic streptococci in the throat in patients with psoriasis vulgaris, with reference to their role in the pathogenesis of this disease. Dermatologica 140:282-90
36. Territo MC, Ganz T, Selsted ME et al. (1989) Monocyte-chemotactic activity of defensins from human neutrophils. J Clin Invest 84:2017-20
37. Wolk K, Kunz S, Witte E et al. (2004) IL-22 increases the innate immunity of tissues. Immunity 21:241-54
38. Wu Z, Hoover DM, Yang D et al. (2003) Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc Natl Acad Sci USA 100:8880-5
39. Yang D, Chertov O, Bykovskaia SN et al. (1999a) Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286:525-8
40. Yang D, Howard OMZ, Chen Q et al. (1999b) Cutting edge: immature dendritic cells generated from monocytes in the presence of TGF-{beta}1 express functional C-C chemokine receptor 6. J Immunol 163: 1737-41